U.S Veterans: 20 of 24 Participants Complete Long-Term Follow-Up

On November 2 and 3, 2015, the 19th and 20th participants completed 12-month follow-up interviews in our largest Phase 2 study of MDMA-assisted psychotherapy for 24 U.S. veterans, firefighters, and police officers with chronic, treatment-resistant PTSD. All treatment sessions have been completed. Led by Principal Investigator Michael Mithoefer, M.D., and Co-Therapist Annie Mithoefer, B.S.N., in Charleston, South Carolina, the data from this study are now being prepared for analysis and publication in a peer-reviewed scientific journal. “When we applied to the FDA for our first study in October 2001, primarily aimed at treating people with crime-related trauma such as childhood sexual abuse, rape, or other assault, we didn’t know that the Afghanistan and Iraq wars would be starting soon,” writes Dr. Mithoefer in his all-new article in the Winter 2015 MAPS Bulletin. “Since then, the need for additional treatments for returning veterans with PTSD has become painfully and increasingly pressing.”